Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 29.1 CHF 0.69% Market Closed
Market Cap: 167.1m CHF
Have any thoughts about
Xlife Sciences AG?
Write Note
XLS
/
Balance Sheet
/
Deferred Income Tax

Xlife Sciences AG
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xlife Sciences AG
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Xlife Sciences AG
SIX:XLS
Deferred Income Tax
CHf85.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Deferred Income Tax
CHf55.7m
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
6%
Siegfried Holding AG
SIX:SFZN
Deferred Income Tax
CHf24.5m
CAGR 3-Years
26%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Deferred Income Tax
CHf491m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tecan Group AG
SIX:TECN
Deferred Income Tax
CHf45.8m
CAGR 3-Years
113%
CAGR 5-Years
50%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Deferred Income Tax
CHf3.9m
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Xlife Sciences AG
Glance View

Market Cap
166m CHF
Industry
Life Sciences Tools & Services

Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Zuerich and currently employs 19 full-time employees. The company went IPO on 2019-09-30. The firm focuses on investing in technologies in the life science industry. The company supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The firm offers its investors direct access to the further development of technologies at a very early stage. The firm cooperates with industrial partners and universities.

XLS Intrinsic Value
1.37 CHF
Overvaluation 95%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Xlife Sciences AG's Deferred Income Tax?
Deferred Income Tax
85.3m CHF

Based on the financial report for Dec 31, 2023, Xlife Sciences AG's Deferred Income Tax amounts to 85.3m CHF.

What is Xlife Sciences AG's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 1Y
-5%

Over the last year, the Deferred Income Tax growth was -5%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.